Use of caryophyllene oxide as an antifungal agent in an in vitro experimental model of onychomycosis

Caryophyllene oxide, an oxygenated terpenoid, well known as preservative in food, drugs and cosmetics, has been tested in vitro as an antifungal against dermatophytes. Its antifungal activity has been compared to ciclopiroxolamine and sulconazole, commonly used in onychomycosis treatment and chosen...

Full description

Saved in:
Bibliographic Details
Published in:Mycopathologia (1975) 1999-11, Vol.148 (2), p.79-82
Main Authors: YANG, Depo, MICHEL, Laura, CHAUMONT, Jean-Pierre, MILLET-CLERC, Joëlle
Format: Article
Language:English
Subjects:
Animals
Antibiotics. Antiinfectious agents. Antiparasitic agents
Antifungal agents
Antifungal Agents - therapeutic use
Biological and medical sciences
caryophyllene oxide
Ciclopirox
Experimental mycoses and models
Fundamental and applied biological sciences. Psychology
Hoof and Claw - drug effects
Hoof and Claw - microbiology
Humans
Imidazoles - therapeutic use
Infectious diseases
Medical sciences
Microbiology
Mycoses
Onychomycosis - drug therapy
Onychomycosis - microbiology
Pharmacology. Drug treatments
Pyridones - therapeutic use
Sesquiterpenes - therapeutic use
Sheep
terpenoids
Trichophyton - drug effects
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c341t-a30186638bc73cd6391096e9060d91d146ad604a18945873f117ee8391edea93
cites
container_end_page 82
container_issue 2
container_start_page 79
container_title Mycopathologia (1975)
container_volume 148
creator YANG, Depo
MICHEL, Laura
CHAUMONT, Jean-Pierre
MILLET-CLERC, Joëlle
description Caryophyllene oxide, an oxygenated terpenoid, well known as preservative in food, drugs and cosmetics, has been tested in vitro as an antifungal against dermatophytes. Its antifungal activity has been compared to ciclopiroxolamine and sulconazole, commonly used in onychomycosis treatment and chosen because of their very different chemical structures. So, a new model has been tested, utilizing sheep hoof plates in order to simulate human nails, which are almost unobtainable for in vitro tests. Three protocols were utilized: pre-treatment, simultaneous treatment and post-treatment. Among these, the post-treatment method was the best to simulate antifungal therapy, as it permitted testing and comparing the efficiency of different antifungal drugs.
doi_str_mv 10.1023/A:1007178924408
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_69508788</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>928832471</sourcerecordid><originalsourceid>FETCH-LOGICAL-c341t-a30186638bc73cd6391096e9060d91d146ad604a18945873f117ee8391edea93</originalsourceid><addsrcrecordid>eNqF0EtLxDAQB_Agiq6Pszcpgt6qM002D28ivkDwsoK3kk2mWmmbtWnF_fZmcUXwIoQEJj-GmT9jhwhnCAU_v7xAAIVKm0II0BtsglPFc9C82GQT4IC50PJ5h-3G-AaQMKpttoOI2iihJsw_RcpClTnbL8Piddk01KXCZ-0pszGzXTpDXY3di20y-0LdkNWr2ur-qIc-ZPS5oL5u008SbfDUrPqFbuleQ7t0IdZxn21Vtol0sH732OzmenZ1lz883t5fXT7kjgsccpvG1VJyPXeKOy-5QTCSDEjwBj0Kab0EYdPsYqoVrxAVkU6MPFnD99jpd9tFH95HikPZ1tFR09iOwhhLaaagldb_wpSnMBogweM_8C2MfZd2KIsCsZBqKhI6WqNx3pIvFymNlGb5E3ICJ2tgo7NN1dvO1fHXCZQopeFfdhKKFw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>221126754</pqid></control><display><type>article</type><title>Use of caryophyllene oxide as an antifungal agent in an in vitro experimental model of onychomycosis</title><source>Springer Link</source><creator>YANG, Depo ; MICHEL, Laura ; CHAUMONT, Jean-Pierre ; MILLET-CLERC, Joëlle</creator><creatorcontrib>YANG, Depo ; MICHEL, Laura ; CHAUMONT, Jean-Pierre ; MILLET-CLERC, Joëlle</creatorcontrib><description>Caryophyllene oxide, an oxygenated terpenoid, well known as preservative in food, drugs and cosmetics, has been tested in vitro as an antifungal against dermatophytes. Its antifungal activity has been compared to ciclopiroxolamine and sulconazole, commonly used in onychomycosis treatment and chosen because of their very different chemical structures. So, a new model has been tested, utilizing sheep hoof plates in order to simulate human nails, which are almost unobtainable for in vitro tests. Three protocols were utilized: pre-treatment, simultaneous treatment and post-treatment. Among these, the post-treatment method was the best to simulate antifungal therapy, as it permitted testing and comparing the efficiency of different antifungal drugs.</description><identifier>ISSN: 0301-486X</identifier><identifier>EISSN: 1573-0832</identifier><identifier>DOI: 10.1023/A:1007178924408</identifier><identifier>PMID: 11189747</identifier><identifier>CODEN: MYCPAH</identifier><language>eng</language><publisher>Dordrecht: Springer</publisher><subject>Animals ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Antifungal agents ; Antifungal Agents - therapeutic use ; Biological and medical sciences ; caryophyllene oxide ; Ciclopirox ; Experimental mycoses and models ; Fundamental and applied biological sciences. Psychology ; Hoof and Claw - drug effects ; Hoof and Claw - microbiology ; Humans ; Imidazoles - therapeutic use ; Infectious diseases ; Medical sciences ; Microbiology ; Mycoses ; Onychomycosis - drug therapy ; Onychomycosis - microbiology ; Pharmacology. Drug treatments ; Pyridones - therapeutic use ; Sesquiterpenes - therapeutic use ; Sheep ; terpenoids ; Trichophyton - drug effects</subject><ispartof>Mycopathologia (1975), 1999-11, Vol.148 (2), p.79-82</ispartof><rights>2002 INIST-CNRS</rights><rights>Kluwer Academic Publishers 1999</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c341t-a30186638bc73cd6391096e9060d91d146ad604a18945873f117ee8391edea93</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=14161669$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11189747$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>YANG, Depo</creatorcontrib><creatorcontrib>MICHEL, Laura</creatorcontrib><creatorcontrib>CHAUMONT, Jean-Pierre</creatorcontrib><creatorcontrib>MILLET-CLERC, Joëlle</creatorcontrib><title>Use of caryophyllene oxide as an antifungal agent in an in vitro experimental model of onychomycosis</title><title>Mycopathologia (1975)</title><addtitle>Mycopathologia</addtitle><description>Caryophyllene oxide, an oxygenated terpenoid, well known as preservative in food, drugs and cosmetics, has been tested in vitro as an antifungal against dermatophytes. Its antifungal activity has been compared to ciclopiroxolamine and sulconazole, commonly used in onychomycosis treatment and chosen because of their very different chemical structures. So, a new model has been tested, utilizing sheep hoof plates in order to simulate human nails, which are almost unobtainable for in vitro tests. Three protocols were utilized: pre-treatment, simultaneous treatment and post-treatment. Among these, the post-treatment method was the best to simulate antifungal therapy, as it permitted testing and comparing the efficiency of different antifungal drugs.</description><subject>Animals</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Antifungal agents</subject><subject>Antifungal Agents - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>caryophyllene oxide</subject><subject>Ciclopirox</subject><subject>Experimental mycoses and models</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Hoof and Claw - drug effects</subject><subject>Hoof and Claw - microbiology</subject><subject>Humans</subject><subject>Imidazoles - therapeutic use</subject><subject>Infectious diseases</subject><subject>Medical sciences</subject><subject>Microbiology</subject><subject>Mycoses</subject><subject>Onychomycosis - drug therapy</subject><subject>Onychomycosis - microbiology</subject><subject>Pharmacology. Drug treatments</subject><subject>Pyridones - therapeutic use</subject><subject>Sesquiterpenes - therapeutic use</subject><subject>Sheep</subject><subject>terpenoids</subject><subject>Trichophyton - drug effects</subject><issn>0301-486X</issn><issn>1573-0832</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><recordid>eNqF0EtLxDAQB_Agiq6Pszcpgt6qM002D28ivkDwsoK3kk2mWmmbtWnF_fZmcUXwIoQEJj-GmT9jhwhnCAU_v7xAAIVKm0II0BtsglPFc9C82GQT4IC50PJ5h-3G-AaQMKpttoOI2iihJsw_RcpClTnbL8Piddk01KXCZ-0pszGzXTpDXY3di20y-0LdkNWr2ur-qIc-ZPS5oL5u008SbfDUrPqFbuleQ7t0IdZxn21Vtol0sH732OzmenZ1lz883t5fXT7kjgsccpvG1VJyPXeKOy-5QTCSDEjwBj0Kab0EYdPsYqoVrxAVkU6MPFnD99jpd9tFH95HikPZ1tFR09iOwhhLaaagldb_wpSnMBogweM_8C2MfZd2KIsCsZBqKhI6WqNx3pIvFymNlGb5E3ICJ2tgo7NN1dvO1fHXCZQopeFfdhKKFw</recordid><startdate>19991101</startdate><enddate>19991101</enddate><creator>YANG, Depo</creator><creator>MICHEL, Laura</creator><creator>CHAUMONT, Jean-Pierre</creator><creator>MILLET-CLERC, Joëlle</creator><general>Springer</general><general>Springer Nature B.V</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7T7</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>19991101</creationdate><title>Use of caryophyllene oxide as an antifungal agent in an in vitro experimental model of onychomycosis</title><author>YANG, Depo ; MICHEL, Laura ; CHAUMONT, Jean-Pierre ; MILLET-CLERC, Joëlle</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c341t-a30186638bc73cd6391096e9060d91d146ad604a18945873f117ee8391edea93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Animals</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Antifungal agents</topic><topic>Antifungal Agents - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>caryophyllene oxide</topic><topic>Ciclopirox</topic><topic>Experimental mycoses and models</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Hoof and Claw - drug effects</topic><topic>Hoof and Claw - microbiology</topic><topic>Humans</topic><topic>Imidazoles - therapeutic use</topic><topic>Infectious diseases</topic><topic>Medical sciences</topic><topic>Microbiology</topic><topic>Mycoses</topic><topic>Onychomycosis - drug therapy</topic><topic>Onychomycosis - microbiology</topic><topic>Pharmacology. Drug treatments</topic><topic>Pyridones - therapeutic use</topic><topic>Sesquiterpenes - therapeutic use</topic><topic>Sheep</topic><topic>terpenoids</topic><topic>Trichophyton - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>YANG, Depo</creatorcontrib><creatorcontrib>MICHEL, Laura</creatorcontrib><creatorcontrib>CHAUMONT, Jean-Pierre</creatorcontrib><creatorcontrib>MILLET-CLERC, Joëlle</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biological Sciences</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Mycopathologia (1975)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>YANG, Depo</au><au>MICHEL, Laura</au><au>CHAUMONT, Jean-Pierre</au><au>MILLET-CLERC, Joëlle</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Use of caryophyllene oxide as an antifungal agent in an in vitro experimental model of onychomycosis</atitle><jtitle>Mycopathologia (1975)</jtitle><addtitle>Mycopathologia</addtitle><date>1999-11-01</date><risdate>1999</risdate><volume>148</volume><issue>2</issue><spage>79</spage><epage>82</epage><pages>79-82</pages><issn>0301-486X</issn><eissn>1573-0832</eissn><coden>MYCPAH</coden><abstract>Caryophyllene oxide, an oxygenated terpenoid, well known as preservative in food, drugs and cosmetics, has been tested in vitro as an antifungal against dermatophytes. Its antifungal activity has been compared to ciclopiroxolamine and sulconazole, commonly used in onychomycosis treatment and chosen because of their very different chemical structures. So, a new model has been tested, utilizing sheep hoof plates in order to simulate human nails, which are almost unobtainable for in vitro tests. Three protocols were utilized: pre-treatment, simultaneous treatment and post-treatment. Among these, the post-treatment method was the best to simulate antifungal therapy, as it permitted testing and comparing the efficiency of different antifungal drugs.</abstract><cop>Dordrecht</cop><pub>Springer</pub><pmid>11189747</pmid><doi>10.1023/A:1007178924408</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0301-486X
ispartof Mycopathologia (1975), 1999-11, Vol.148 (2), p.79-82
issn 0301-486X
1573-0832
language eng
recordid cdi_proquest_miscellaneous_69508788
source Springer Link
subjects Animals
Antibiotics. Antiinfectious agents. Antiparasitic agents
Antifungal agents
Antifungal Agents - therapeutic use
Biological and medical sciences
caryophyllene oxide
Ciclopirox
Experimental mycoses and models
Fundamental and applied biological sciences. Psychology
Hoof and Claw - drug effects
Hoof and Claw - microbiology
Humans
Imidazoles - therapeutic use
Infectious diseases
Medical sciences
Microbiology
Mycoses
Onychomycosis - drug therapy
Onychomycosis - microbiology
Pharmacology. Drug treatments
Pyridones - therapeutic use
Sesquiterpenes - therapeutic use
Sheep
terpenoids
Trichophyton - drug effects
title Use of caryophyllene oxide as an antifungal agent in an in vitro experimental model of onychomycosis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T04%3A52%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Use%20of%20caryophyllene%20oxide%20as%20an%20antifungal%20agent%20in%20an%20in%20vitro%20experimental%20model%20of%20onychomycosis&rft.jtitle=Mycopathologia%20(1975)&rft.au=YANG,%20Depo&rft.date=1999-11-01&rft.volume=148&rft.issue=2&rft.spage=79&rft.epage=82&rft.pages=79-82&rft.issn=0301-486X&rft.eissn=1573-0832&rft.coden=MYCPAH&rft_id=info:doi/10.1023/A:1007178924408&rft_dat=%3Cproquest_pubme%3E928832471%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c341t-a30186638bc73cd6391096e9060d91d146ad604a18945873f117ee8391edea93%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=221126754&rft_id=info:pmid/11189747&rfr_iscdi=true